Coronary Stents Market - Global Outlook and forecast 2019-2024
The global coronary stent market is likely to reach more than $11 billion by 2024, growing at a CAGR of around 7% during 2018–2024.
The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.
The growing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the coronary stent market. Over the years, coronary stents have witnessed several technological enhancements, particularly design innovations. Stent manufacturers are focusing primarily on R&D activities and commercialization of innovative drug-eluting stent (DES) systems due to the high prevalence of coronary artery diseases.
New product approvals are contributing majorly toward the growth of the market and are likely to have a significant impact on the adoption of coronary stents in the coming years. Abbott, B. Braun Melsungen, Boston Scientific, Biosensors International GroupMedtronic, BIOTRONIK, Microport Scientific, and Terumo have launched a diverse range of drug-eluting stents in recent years, which are expected to augur well for the growth of the coronary stent market.
The market research report on the coronary stent market covers market sizing and forecast, market share, industry trends, growth drivers, and vendor analysis. The market study includes insights on segmentation by product (drug-eluting stents, bare metal stents, and bioresorbable stents), design (permanent, fully degradable), end-users (hospitals, specialty cardiology centers, ambulatory surgical centers), and geography (North America, Europe, APAC, Latin America, and MEA).
Coronary Stent Market: Segmentation
The market research report includes a detailed segmentation of the market by product, design, end-users, and geography. Bare metal stents are growing at a steady rate. High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth bare metal stents. Further, the demand for bare metal stents is likely to grow primarily from price-sensitive markets such as developing and low-income countries, where the uptake of PCI procedures has steadily increased over the past few years.
Bioresorbable stents are growing at a faster pace and are likely to witness rapid growth during the forecast period. With the availability of a few commercial and promising investigational devices, bioresorbable stents are likely to offer tremendous growth opportunities for vendors in coming years.
The permanent coronary stents segment is growing significantly and captured more than half of the market in 2018. Permanent heart stents are non-degradable devices made up from metal alloys such as stainless steel, cobalt chromium, and platinum chromium. They are gaining prominence in the market due to their safety and efficacy.
Fully degradable heart stents are growing at a stable rate. The rise in CVDs, especially vascular diseases, has become a major growth driver for innovative fully degradable types. Further, the heart stent manufacturers are focusing on R&D activities and commercialization of innovative products such as BRSs.Several emerging and major players are actively engaged in the development and commercialization of BRSs due to their huge market potential. For instance, Abbott is developing Absorb, second-generation BRS, and is actively conducting clinical trials to gain regulatory approvals.
Hospitals are the largest end-users of coronary stents. The growing aging population, changing lifestyle patterns, and the increasing prevalence of CVDs are fueling market growth. Further, a significant number of patients prefer to undergo surgeries in hospitals due to better reimbursement policies. The availability of reimbursement in hospitals is a major driver for the high volume of PCI procedures in the healthcare sector.The demand for highly advanced and innovative PCI procedures like robot-assisted techniques are being performed to implant a diverse array of drug eluting, bare metal, and bioabsorbable stents.
Market Segmentation by Product
North America captured half of the global coronary stent market in 2018. The presence of a large pool of patient population with CAD requiring coronary stents, a high acceptance of advanced and innovative heart stents, and high awareness toward stent-based PCI procedures have collectively supported North America’s dominance in the market.
Germany, the UK, France, Italy, and Spain are the major revenue contributors in the coronary stent market in Europe. The presence of highly sophisticated healthcare infrastructure, high awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents are major driver driving the Europe coronary stent market.
Market Segmentation by Geography
The coronary stent market is highly dynamic due to the presence of several global, regional, and local players offering a broad range of stents. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and investments in startup and emerging companies to expand their presence, enhance product portfolio, and improve expertise in the market. Leading players are focusing on implementing strategies such as product approvals, expanded indication approvals, conducting clinical trials, marketing, and promotional activities, acquisitions, increase R&D investment, and strengthen their distribution networks to enhance their market share and presence in the coronary stent market.
Prominent Vendors
The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.
The growing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the coronary stent market. Over the years, coronary stents have witnessed several technological enhancements, particularly design innovations. Stent manufacturers are focusing primarily on R&D activities and commercialization of innovative drug-eluting stent (DES) systems due to the high prevalence of coronary artery diseases.
New product approvals are contributing majorly toward the growth of the market and are likely to have a significant impact on the adoption of coronary stents in the coming years. Abbott, B. Braun Melsungen, Boston Scientific, Biosensors International GroupMedtronic, BIOTRONIK, Microport Scientific, and Terumo have launched a diverse range of drug-eluting stents in recent years, which are expected to augur well for the growth of the coronary stent market.
The market research report on the coronary stent market covers market sizing and forecast, market share, industry trends, growth drivers, and vendor analysis. The market study includes insights on segmentation by product (drug-eluting stents, bare metal stents, and bioresorbable stents), design (permanent, fully degradable), end-users (hospitals, specialty cardiology centers, ambulatory surgical centers), and geography (North America, Europe, APAC, Latin America, and MEA).
Coronary Stent Market: Segmentation
The market research report includes a detailed segmentation of the market by product, design, end-users, and geography. Bare metal stents are growing at a steady rate. High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth bare metal stents. Further, the demand for bare metal stents is likely to grow primarily from price-sensitive markets such as developing and low-income countries, where the uptake of PCI procedures has steadily increased over the past few years.
Bioresorbable stents are growing at a faster pace and are likely to witness rapid growth during the forecast period. With the availability of a few commercial and promising investigational devices, bioresorbable stents are likely to offer tremendous growth opportunities for vendors in coming years.
The permanent coronary stents segment is growing significantly and captured more than half of the market in 2018. Permanent heart stents are non-degradable devices made up from metal alloys such as stainless steel, cobalt chromium, and platinum chromium. They are gaining prominence in the market due to their safety and efficacy.
Fully degradable heart stents are growing at a stable rate. The rise in CVDs, especially vascular diseases, has become a major growth driver for innovative fully degradable types. Further, the heart stent manufacturers are focusing on R&D activities and commercialization of innovative products such as BRSs.Several emerging and major players are actively engaged in the development and commercialization of BRSs due to their huge market potential. For instance, Abbott is developing Absorb, second-generation BRS, and is actively conducting clinical trials to gain regulatory approvals.
Hospitals are the largest end-users of coronary stents. The growing aging population, changing lifestyle patterns, and the increasing prevalence of CVDs are fueling market growth. Further, a significant number of patients prefer to undergo surgeries in hospitals due to better reimbursement policies. The availability of reimbursement in hospitals is a major driver for the high volume of PCI procedures in the healthcare sector.The demand for highly advanced and innovative PCI procedures like robot-assisted techniques are being performed to implant a diverse array of drug eluting, bare metal, and bioabsorbable stents.
Market Segmentation by Product
- Drug-eluting stents
- Bare metal stents
- Bioresorbable stents
- Permanent coronary stents
- Fully degradable coronary stents
- Hospitals
- Specialty cardiology centers
- Ambulatory surgical centers
North America captured half of the global coronary stent market in 2018. The presence of a large pool of patient population with CAD requiring coronary stents, a high acceptance of advanced and innovative heart stents, and high awareness toward stent-based PCI procedures have collectively supported North America’s dominance in the market.
Germany, the UK, France, Italy, and Spain are the major revenue contributors in the coronary stent market in Europe. The presence of highly sophisticated healthcare infrastructure, high awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents are major driver driving the Europe coronary stent market.
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- APAC
- China
- India
- Japan
- Latin America
- Mexico
- Brazil
- MEA
- Turkey
- Saudi Arabia
The coronary stent market is highly dynamic due to the presence of several global, regional, and local players offering a broad range of stents. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and investments in startup and emerging companies to expand their presence, enhance product portfolio, and improve expertise in the market. Leading players are focusing on implementing strategies such as product approvals, expanded indication approvals, conducting clinical trials, marketing, and promotional activities, acquisitions, increase R&D investment, and strengthen their distribution networks to enhance their market share and presence in the coronary stent market.
Prominent Vendors
- Abbott
- Boston Scientific
- Medtronic
- BIOTRONIK
- Terumo
- Braun Melsungen
- Biosensors International Group
- Arterial Remodeling Technologies
- Alvimedica
- Balton
- Cardionovum
- CeloNovaBioSciences
- Comed
- Cordis
- Elixir Medical
- Endocor
- Eucatech
- Eurocor Tech
- Hexacath
- InSitu Technologies
- Innovative Healthcare Technologies
- Lepu Medical Technology (Beijing)
- Medinol
- Meril Life Sciences
- Micell Technologies
- MicroPort Scientific
- Minvasys
- OrbuSneich Medical
- Q3 Medical Devices
- REVA Medical
- Rontis
- S3V Vascular Technologies
- Sahajanand Medical Technologies
- SCITECH
- Stentys
- Svelte Medical
- Translumina Therapeutics
- USM Healthcare
- Vascular Concepts
- Wellinq
- Offers market sizing and growth prospects of functional coronary stent market for the forecast period 2019–2024
- Provides comprehensive insights on the latest industry trends, market forecast, and growth drivers in the coronary stent market
- Includes a detailed analysis of market growth drivers, challenges, and investment opportunities
- Delivers a complete overview of market segments and the regional outlook of coronary stent market
- Offers an exhaustive summary of the vendor landscape, competitive analysis, and key market strategies to gain a competitive advantage in the coronary stent market
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Design
4.4.3 Market Segmentation by End-users
4.4.4 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Coronary Artery Disease (CAD): An Overview
7.1.1 Symptoms
7.1.3 Etiology
7.1.4 Complications
7.1.5 Diagnosis
7.1.6 Treatment
7.2 PCI: An Overview
7.2.1 Coronary Stents
8 MARKET DYNAMICS
8.1 Market Growth Enablers
8.1.1 Increased Prevalence/Incidence of Coronary Artery Disease
8.1.2 High Demand for DESs with Low Strut Thickness
8.1.3 High Demand for Coronary Stents in Emerging Markets
8.1.4 Technological Advancements/Innovations in Stent Platforms
8.2 Market Growth Restraints
8.2.1 Stringent Regulations for Product Approvals
8.2.2 Availability of Alternative Treatment Methods for CAD
8.2.3 Complications Associated with Coronary Stenting Procedure
8.3 Market Opportunities & Trends
8.3.1 Emergence of Bioresorbable Vascular Scaffolds
8.3.2 High Growth Potential of Third-generation DESs
8.3.3 New Product Approvals/Launches
9 GLOBAL CORONARY STENTS MARKET
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 BY PRODUCT TYPE
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Drug-eluting Stents
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.3.3 Global Drug-eluting Stents Market by Product Type
10.3.4 Second-generation Drug-eluting Stents: Market Size & Forecast
10.3.5 Latest-generation Drug-eluting Stents: Market Size & Forecast
10.4 Bare Metal Stents
10.4.1 Market Overview
10.4.2 Market Size & Forecast
10.5 Bioresorbable Stents
10.5.1 Market Overview
10.5.2 Market Size & Forecast
11 BY DESIGN TYPE
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Permanent Coronary Stents
11.3.1 Market Size & Forecast
11.4 Fully Degradable Coronary Stents
11.4.1 Market Size & Forecast
12 BY END-USERS
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hospitals
12.3.1 Market Size & Forecast
12.4 Specialty Cardiology Centers
12.4.1 Market Size & Forecast
12.5 ASCs
12.5.1 Market Size & Forecast
13 BY GEOGRAPHY
13.1 Market Snapshot & Growth Engine
13.2 Overview
14 NORTH AMERICA
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Key Countries
14.3.1 US: Market Size & Forecast
14.3.2 Canada: Market Size & Forecast
15 EUROPE
15.1 Market Overview
15.1.1 Market Size & Forecast
15.2 Key Countries
15.2.1 Germany: Market Size & Forecast
15.2.2 France: Market Size & Forecast
15.2.3 UK: Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Japan: Market Size & Forecast
16.3.2 China: Market Size & Forecast
16.3.3 India: Market Size & Forecast
17 LATIN AMERICA
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Brazil: Market Size & Forecast
17.3.2 Mexico: Market Size & Forecast
18 MIDDLE-EAST AND AFRICA
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Turkey: Market Size & Forecast
18.3.2 Saudi Arabia: Market Size & Forecast
19 COMPETITIVE LANDSCAPE
19.1 Competition Overview
19.2 Market Share Analysis
20 KEY COMPANY PROFILES
20.1 Abbott
20.1.1 Business Overview
20.1.2 Abbott in Global Coronary Stents Market
20.1.3 Major Product Offerings
20.1.4 Key Strategies
20.1.5 Key Strengths
20.1.6 Key Opportunities
20.2 Boston Scientific
20.2.1 Business Overview
20.2.2 Boston Scientific in Global Coronary Stents Market
20.2.3 Major Product Offerings
20.2.4 Key Strategies
20.2.5 Key Strengths
20.2.6 Key Opportunities
20.3 Medtronic
20.3.1 Business Overview
20.3.2 Medtronic in Global Coronary Stent Market
20.3.3 Major Product Offerings
20.3.4 Key Strategies
20.3.5 Key Strengths
20.3.6 Key Opportunities
20.4 Biotronik
20.4.1 Business Overview
20.4.2 BIOTRONIK in Global Coronary Stents Market
20.4.3 Major Product Offerings
20.4.4 Key Strategies
20.4.5 Key Strengths
20.4.6 Key Opportunities
20.5 Terumo
20.5.1 Business Overview
20.5.2 Terumo in Global Coronary Stents Market
20.5.3 Product Offerings
20.5.4 Key Strategies
20.5.5 Key Strengths
20.5.6 Key Opportunities
20.6 B. Braun Melsungen
20.6.1 Business Overview
20.6.2 B. Braun Melsungen in Global Coronary Stents Market
20.6.3 Major Product Offerings
20.6.4 Key Strategies
20.6.5 Key Strengths
20.6.6 Key Opportunities
20.7 Biosensors International Group
20.7.1 Business Overview
20.7.2 Biosensors International Group in Global Coronary Stents Market
20.7.3 Major Product Offerings
20.7.4 Key Strategies
20.7.5 Key Strengths
20.7.6 Key Opportunities
21 OTHER PROMINENT VENDORS
21.1 Arterial Remodeling Technologies
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.2 Alvimedica
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.3 Balton
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.5 Cardionovum
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.6 CeloNova BioSciences
21.6.1 Business Overview
21.6.2 Major Product Offerings
21.7 Comed
21.7.1 Business Overview
21.7.2 Major Product Offerings
21.8 Cordis
21.8.1 Business Overview
21.8.2 Major Product Offerings
21.9 Elixir Medical
21.9.1 Business Overview
21.9.2 Major Product Offerings
21.10 ENDOCOR
21.10.1 Business Overview
21.10.2 Major Product Offerings
21.11 Eucatech
21.11.1 Business Overview
21.11.2 Major Product Offerings
21.12 Eurocor Tech
21.12.1 Business Overview
21.12.2 Major Product Offerings
21.13 HEXACATH
21.13.1 Business Overview
21.13.2 Major Product Offerings
21.14 InSitu Technologies
21.14.1 Business Overview
21.14.2 Major Product Offerings
21.15 Innovative Health Technologies
21.15.1 Business Overview
21.15.2 Major Product Offerings
21.16 Lepu Medical Technology (Beijing)
21.16.1 Business Overview
21.16.2 Major Product Offerings
21.17 Medinol
21.17.1 Business Overview
21.17.2 Major Product Offerings
21.18 Meril Life Sciences
21.18.1 Business Overview
21.18.2 Major Product Offerings
21.19 Micell Technologies
21.19.1 Business Overview
21.19.2 Major Product Offerings
21.20 MicroPort Scientific
21.20.1 Business Overview
21.20.2 Major Product Offerings
21.21 Minvasys
21.21.1 Business Overview
21.21.2 Major Product Offerings
21.22 ORBUSNEICH MEDICAL
21.22.1 Business Overview
21.22.2 Major Product Offerings
21.23 Q3 Medical Devices
21.23.1 Business Overview
21.23.2 Major Product Offerings
21.24 REVA Medical
21.24.1 Business Overview
21.24.2 Major Product Offerings
21.25 Rontis
21.25.1 Business Overview
21.25.2 Major Product Offerings
21.26 S3V Vascular Technologies
21.26.1 Business Overview
21.26.2 Major Product Offerings
21.27 Sahajanand Medical Technologies
21.27.1 Business Overview
21.27.2 Major Product Offerings
21.28 SCITECH
21.28.1 Business Overview
21.28.2 Major Product Offerings
21.29 STENTYS
21.29.1 Business Overview
21.29.2 Major Product Offerings
21.30 Svelte Medical
21.30.1 Business Overview
21.30.2 Major Product Offerings
21.31 Translumina Therapeutics
21.31.1 Business Overview
21.31.2 Major Product Offerings
21.32 USM HEALTHCARE
21.32.1 Business Overview
21.32.2 Major Product Offerings
21.33 Vascular Concepts
21.33.1 Business Overview
21.33.2 Major Product Offerings
21.34 Wellinq
21.34.1 Business Overview
21.34.2 Major Product Offerings
22 REPORT SUMMARY
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 Product Type
22.3.2 Design Type
22.3.3 End-Users
22.3.4 Geography
23 APPENDIX
23.1 Abbreviations
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Design
4.4.3 Market Segmentation by End-users
4.4.4 Market Segmentation by Geography
5 REPORT ASSUMPTIONS & CAVEATS
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 Coronary Artery Disease (CAD): An Overview
7.1.1 Symptoms
7.1.3 Etiology
7.1.4 Complications
7.1.5 Diagnosis
7.1.6 Treatment
7.2 PCI: An Overview
7.2.1 Coronary Stents
8 MARKET DYNAMICS
8.1 Market Growth Enablers
8.1.1 Increased Prevalence/Incidence of Coronary Artery Disease
8.1.2 High Demand for DESs with Low Strut Thickness
8.1.3 High Demand for Coronary Stents in Emerging Markets
8.1.4 Technological Advancements/Innovations in Stent Platforms
8.2 Market Growth Restraints
8.2.1 Stringent Regulations for Product Approvals
8.2.2 Availability of Alternative Treatment Methods for CAD
8.2.3 Complications Associated with Coronary Stenting Procedure
8.3 Market Opportunities & Trends
8.3.1 Emergence of Bioresorbable Vascular Scaffolds
8.3.2 High Growth Potential of Third-generation DESs
8.3.3 New Product Approvals/Launches
9 GLOBAL CORONARY STENTS MARKET
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 BY PRODUCT TYPE
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Drug-eluting Stents
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.3.3 Global Drug-eluting Stents Market by Product Type
10.3.4 Second-generation Drug-eluting Stents: Market Size & Forecast
10.3.5 Latest-generation Drug-eluting Stents: Market Size & Forecast
10.4 Bare Metal Stents
10.4.1 Market Overview
10.4.2 Market Size & Forecast
10.5 Bioresorbable Stents
10.5.1 Market Overview
10.5.2 Market Size & Forecast
11 BY DESIGN TYPE
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Permanent Coronary Stents
11.3.1 Market Size & Forecast
11.4 Fully Degradable Coronary Stents
11.4.1 Market Size & Forecast
12 BY END-USERS
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Hospitals
12.3.1 Market Size & Forecast
12.4 Specialty Cardiology Centers
12.4.1 Market Size & Forecast
12.5 ASCs
12.5.1 Market Size & Forecast
13 BY GEOGRAPHY
13.1 Market Snapshot & Growth Engine
13.2 Overview
14 NORTH AMERICA
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Key Countries
14.3.1 US: Market Size & Forecast
14.3.2 Canada: Market Size & Forecast
15 EUROPE
15.1 Market Overview
15.1.1 Market Size & Forecast
15.2 Key Countries
15.2.1 Germany: Market Size & Forecast
15.2.2 France: Market Size & Forecast
15.2.3 UK: Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Japan: Market Size & Forecast
16.3.2 China: Market Size & Forecast
16.3.3 India: Market Size & Forecast
17 LATIN AMERICA
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Brazil: Market Size & Forecast
17.3.2 Mexico: Market Size & Forecast
18 MIDDLE-EAST AND AFRICA
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Turkey: Market Size & Forecast
18.3.2 Saudi Arabia: Market Size & Forecast
19 COMPETITIVE LANDSCAPE
19.1 Competition Overview
19.2 Market Share Analysis
20 KEY COMPANY PROFILES
20.1 Abbott
20.1.1 Business Overview
20.1.2 Abbott in Global Coronary Stents Market
20.1.3 Major Product Offerings
20.1.4 Key Strategies
20.1.5 Key Strengths
20.1.6 Key Opportunities
20.2 Boston Scientific
20.2.1 Business Overview
20.2.2 Boston Scientific in Global Coronary Stents Market
20.2.3 Major Product Offerings
20.2.4 Key Strategies
20.2.5 Key Strengths
20.2.6 Key Opportunities
20.3 Medtronic
20.3.1 Business Overview
20.3.2 Medtronic in Global Coronary Stent Market
20.3.3 Major Product Offerings
20.3.4 Key Strategies
20.3.5 Key Strengths
20.3.6 Key Opportunities
20.4 Biotronik
20.4.1 Business Overview
20.4.2 BIOTRONIK in Global Coronary Stents Market
20.4.3 Major Product Offerings
20.4.4 Key Strategies
20.4.5 Key Strengths
20.4.6 Key Opportunities
20.5 Terumo
20.5.1 Business Overview
20.5.2 Terumo in Global Coronary Stents Market
20.5.3 Product Offerings
20.5.4 Key Strategies
20.5.5 Key Strengths
20.5.6 Key Opportunities
20.6 B. Braun Melsungen
20.6.1 Business Overview
20.6.2 B. Braun Melsungen in Global Coronary Stents Market
20.6.3 Major Product Offerings
20.6.4 Key Strategies
20.6.5 Key Strengths
20.6.6 Key Opportunities
20.7 Biosensors International Group
20.7.1 Business Overview
20.7.2 Biosensors International Group in Global Coronary Stents Market
20.7.3 Major Product Offerings
20.7.4 Key Strategies
20.7.5 Key Strengths
20.7.6 Key Opportunities
21 OTHER PROMINENT VENDORS
21.1 Arterial Remodeling Technologies
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.2 Alvimedica
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.3 Balton
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.5 Cardionovum
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.6 CeloNova BioSciences
21.6.1 Business Overview
21.6.2 Major Product Offerings
21.7 Comed
21.7.1 Business Overview
21.7.2 Major Product Offerings
21.8 Cordis
21.8.1 Business Overview
21.8.2 Major Product Offerings
21.9 Elixir Medical
21.9.1 Business Overview
21.9.2 Major Product Offerings
21.10 ENDOCOR
21.10.1 Business Overview
21.10.2 Major Product Offerings
21.11 Eucatech
21.11.1 Business Overview
21.11.2 Major Product Offerings
21.12 Eurocor Tech
21.12.1 Business Overview
21.12.2 Major Product Offerings
21.13 HEXACATH
21.13.1 Business Overview
21.13.2 Major Product Offerings
21.14 InSitu Technologies
21.14.1 Business Overview
21.14.2 Major Product Offerings
21.15 Innovative Health Technologies
21.15.1 Business Overview
21.15.2 Major Product Offerings
21.16 Lepu Medical Technology (Beijing)
21.16.1 Business Overview
21.16.2 Major Product Offerings
21.17 Medinol
21.17.1 Business Overview
21.17.2 Major Product Offerings
21.18 Meril Life Sciences
21.18.1 Business Overview
21.18.2 Major Product Offerings
21.19 Micell Technologies
21.19.1 Business Overview
21.19.2 Major Product Offerings
21.20 MicroPort Scientific
21.20.1 Business Overview
21.20.2 Major Product Offerings
21.21 Minvasys
21.21.1 Business Overview
21.21.2 Major Product Offerings
21.22 ORBUSNEICH MEDICAL
21.22.1 Business Overview
21.22.2 Major Product Offerings
21.23 Q3 Medical Devices
21.23.1 Business Overview
21.23.2 Major Product Offerings
21.24 REVA Medical
21.24.1 Business Overview
21.24.2 Major Product Offerings
21.25 Rontis
21.25.1 Business Overview
21.25.2 Major Product Offerings
21.26 S3V Vascular Technologies
21.26.1 Business Overview
21.26.2 Major Product Offerings
21.27 Sahajanand Medical Technologies
21.27.1 Business Overview
21.27.2 Major Product Offerings
21.28 SCITECH
21.28.1 Business Overview
21.28.2 Major Product Offerings
21.29 STENTYS
21.29.1 Business Overview
21.29.2 Major Product Offerings
21.30 Svelte Medical
21.30.1 Business Overview
21.30.2 Major Product Offerings
21.31 Translumina Therapeutics
21.31.1 Business Overview
21.31.2 Major Product Offerings
21.32 USM HEALTHCARE
21.32.1 Business Overview
21.32.2 Major Product Offerings
21.33 Vascular Concepts
21.33.1 Business Overview
21.33.2 Major Product Offerings
21.34 Wellinq
21.34.1 Business Overview
21.34.2 Major Product Offerings
22 REPORT SUMMARY
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 Product Type
22.3.2 Design Type
22.3.3 End-Users
22.3.4 Geography
23 APPENDIX
23.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Coronary Stents Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Evolution of Coronary Stents for Treating CAD
Exhibit 4 Different Types of Coronary Stents Available in the Market
Exhibit 5 Impact of Increased Prevalence/Incidence of Coronary Artery Disease
Exhibit 6 Impact of High Demand for DESs with Low Strut Thickness
Exhibit 7 Impact of High Demand for Coronary Stents in Emerging Markets
Exhibit 8 Incremental Growth of Coronary Stents Market in India
Exhibit 9 Incremental Growth of Coronary Stents Market in China
Exhibit 10 Impact of Technological Advancements/Innovations in Stent Platforms
Exhibit 11 Impact of Stringent Regulations for Product Approvals
Exhibit 12 Impact of Availability of Alternative Treatment Methods for CAD
Exhibit 13 Impact of Complications Associated with Coronary Stenting Procedure
Exhibit 14 Impact of Emergence of Bioresorbable Vascular Scaffolds
Exhibit 15 Impact of High Growth Potential of Third-generation DESs
Exhibit 16 Impact of New Product Approvals/Launches
Exhibit 17 Global Coronary Stents Market by Product Type 2018 (%)
Exhibit 18 Global Coronary Stents Market By Geography 2018 & 2024 (%)
Exhibit 19 Global Coronary Stents Market: Key Countries
Exhibit 20 Global Coronary Stents Market By Region: Incremental Growth
Exhibit 21 Global Coronary Stents Market 2018−2024 ($ million)
Exhibit 22 Five Forces Analysis 2018
Exhibit 23 Incremental Growth by Product 2018−2024
Exhibit 24 Global Coronary Stents Market by Product Type
Exhibit 25 Global Coronary Stents Market by Product Type 2018 & 2024 (%)
Exhibit 26 Global Coronary Stents Market by Product Type 2018−2024 ($ million)
Exhibit 27 Global Coronary Stents Market by Product Type 2018−2024 (%)
Exhibit 28 Global Coronary Stents Market by Product Type: Absolute Growth
Exhibit 29 Global Drug-eluting Coronary Stents Market 2018−2024 ($ million)
Exhibit 30 Global Drug-eluting Stents Market by Product Type
Exhibit 31 Global Drug-eluting Stents Market by Product Type 2018 & 2024 (%)
Exhibit 32 Global Drug-eluting Stents Market by Product Type 2018−2024 ($ million)
Exhibit 33 Global Drug-eluting Stents Market by Product Type 2018−2024 (%)
Exhibit 34 Global Second-generation Drug-eluting Stents Market 2018−2024 ($ million)
Exhibit 35 Global Latest-generation Drug-eluting Stents Market 2018−2024 ($ million)
Exhibit 36 Global Bare Metal Coronary Stents Market 2018−2024 ($ million)
Exhibit 37 Global Bioresorbable Coronary Stents Market 2018−2024 ($ million)
Exhibit 38 Incremental Growth by Design 2018−2024
Exhibit 39 Global Coronary Stents Market by Design Type
Exhibit 40 Global Coronary Stents Market by Design Type 2018 & 2024 (%)
Exhibit 41 Global Coronary Stents Market by Design Type 2018−2024 ($ million)
Exhibit 42 Global Coronary Stents Market by Design Type 2018−2024 (%)
Exhibit 43 Global Coronary Stents Market by Design Type: Absolute Growth
Exhibit 44 Global Permanent Coronary Stents Market by Product 2018 (%)
Exhibit 45 Global Permanent Coronary Stents Market 2018−2024 ($ million)
Exhibit 46 Global Fully Degradable Coronary Stents Market 2018−2024 ($ million)
Exhibit 47 Incremental Growth by End-users 2018−2024
Exhibit 48 Global Coronary Stents Market by End-user Type
Exhibit 49 Global Coronary Stents Market by End-users: Absolute Growth
Exhibit 50 Global Coronary Stents Market by End-user Type 2018 & 2024 (%)
Exhibit 51 Global Coronary Stents Market by End-user Type 2018−2024 ($ million)
Exhibit 52 Global Coronary Stents Market by End-user Type 2018−2024 (%)
Exhibit 53 Global Coronary Stents Hospitals Market 2018–2024 ($ million)
Exhibit 54 Global Coronary Stents Market by SCCs 2018–2024 ($ million)
Exhibit 55 Global Coronary Stents Market by ASCs 2018–2024 ($ million)
Exhibit 56 Incremental Growth by Geography 2018−2024
Exhibit 57 Global Coronary Stents Market by Geography
Exhibit 58 Global Coronary Stents Market by Region: Market Share & CAGR
Exhibit 59 Global Coronary Stents Market by Region: Absolute Growth
Exhibit 60 Global Coronary Stents Market by Geography 2018 & 2024 (%)
Exhibit 61 Global Coronary Stents Market by Geography 2018 & 2024 (%)
Exhibit 62 Global Coronary Stents Market by Geography 2018 & 2024 (%)
Exhibit 63 Coronary Stents Market in North America by Country 2018 (%)
Exhibit 64 Coronary Stents Market in North America 2018–2024 ($)
Exhibit 65 Incremental Growth in North America 2018−2024
Exhibit 66 Coronary Stents Market in US 2018–2024 ($ million)
Exhibit 67 Coronary Stents Market in Canada 2018−2024 ($ million)
Exhibit 68 Coronary Stents Market in Europe: Key Countries
Exhibit 69 Coronary Stents Market in Europe 2018−2024 ($ million)
Exhibit 70 Incremental Growth in Europe 2018−2024
Exhibit 71 Coronary Stents Market in Germany 2018−2024 ($ million)
Exhibit 72 Coronary Stents Market in France 2018−2024 ($ million)
Exhibit 73 Coronary Stents Market in UK 2018−2024 ($ million)
Exhibit 74 Incremental Growth Comparison Across Regions During Forecast Period ($ Mn)
Exhibit 75 Coronary Stents Market in APAC: Key Countries
Exhibit 76 Coronary Stents Market in APAC 2018−2024 ($ million)
Exhibit 77 Incremental Growth in APAC 2018−2024
Exhibit 78 Coronary Stents Market in Japan 2018−2024 ($ million)
Exhibit 79 Coronary Stents Market in China 2018−2024 ($ million)
Exhibit 80 Major Factors Driving Coronary Stents Market in India
Exhibit 81 Coronary Stents Market in India 2018−2024 ($ million)
Exhibit 82 Coronary Stents Market in Latin America: Key Countries
Exhibit 83 Coronary Stents Market in Latin America 2018−2024 ($ million)
Exhibit 84 Incremental Growth in Latin America 2018−2024
Exhibit 85 Coronary Stents Market in Brazil 2018−2024 ($ million)
Exhibit 86 Coronary Stents Market in Mexico 2018−2024 ($ million)
Exhibit 87 Coronary Stents Market in MEA: Key Countries
Exhibit 88 Coronary Stents Market in MEA 2018−2024 ($ million)
Exhibit 89 Incremental Growth in MEA 2018−2024
Exhibit 90 Coronary Stents Market in Turkey 2018−2024 ($ million)
Exhibit 91 Coronary Stents Market in Saudi Arabia 2018−2024 ($ million)
Exhibit 92 Global Coronary Stents Market: Vendors Market Share 2018 (%)
Exhibit 93 Global Coronary Stents Market: Top Vendors Market Shares 2018 (%)
Exhibit 94 Abbott: R&D Spend in FY2016, FY2017 and FY2018 ($ million)
Exhibit 95 Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)
Exhibit 96 Abbott Sales Breakdown by Geography 2018 (%)
Exhibit 97 Boston Scientific: R&D Expenditure in FY16, FY17 and FY18 ($ million)
Exhibit 98 Boston Scientific: Revenue Breakdown by Product Category 2017 and 2018 ($ million)
Exhibit 99 Boston Scientific: Revenue Share by Geography 2018 (%)
Exhibit 100 Medtronic Sales Breakdown by Segments FY2018 (%)
Exhibit 101 Medtronic R&D Expenditure FY16-FY18 ($ million)
Exhibit 102 Medtronic Revenue Breakdown by Geography FY2018 (%)
Exhibit 103 Medtronic Revenue by Business Segments in FY17 and FY18 ($ million)
Exhibit 104 Terumo: Research & Development Spend in FY15, FY16, and FY17 ($ million)
Exhibit 105 Terumo: Sales by Business Segment in FY2017 (%)
Exhibit 106 Terumo: Cardiovascular Revenue by Geography FY2017 (%)
Exhibit 107 B. Braun Melsungen R&D Expenditure in FY16, FY17, and FY18 ($ million)
Exhibit 108 B. Braun Melsungen Revenue by Division FY2017 and FY2018 ($ million)
Exhibit 109 B. Braun Melsungen Sales by Region FY18 (%)
Exhibit 1 Segmentation of Global Coronary Stents Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Evolution of Coronary Stents for Treating CAD
Exhibit 4 Different Types of Coronary Stents Available in the Market
Exhibit 5 Impact of Increased Prevalence/Incidence of Coronary Artery Disease
Exhibit 6 Impact of High Demand for DESs with Low Strut Thickness
Exhibit 7 Impact of High Demand for Coronary Stents in Emerging Markets
Exhibit 8 Incremental Growth of Coronary Stents Market in India
Exhibit 9 Incremental Growth of Coronary Stents Market in China
Exhibit 10 Impact of Technological Advancements/Innovations in Stent Platforms
Exhibit 11 Impact of Stringent Regulations for Product Approvals
Exhibit 12 Impact of Availability of Alternative Treatment Methods for CAD
Exhibit 13 Impact of Complications Associated with Coronary Stenting Procedure
Exhibit 14 Impact of Emergence of Bioresorbable Vascular Scaffolds
Exhibit 15 Impact of High Growth Potential of Third-generation DESs
Exhibit 16 Impact of New Product Approvals/Launches
Exhibit 17 Global Coronary Stents Market by Product Type 2018 (%)
Exhibit 18 Global Coronary Stents Market By Geography 2018 & 2024 (%)
Exhibit 19 Global Coronary Stents Market: Key Countries
Exhibit 20 Global Coronary Stents Market By Region: Incremental Growth
Exhibit 21 Global Coronary Stents Market 2018−2024 ($ million)
Exhibit 22 Five Forces Analysis 2018
Exhibit 23 Incremental Growth by Product 2018−2024
Exhibit 24 Global Coronary Stents Market by Product Type
Exhibit 25 Global Coronary Stents Market by Product Type 2018 & 2024 (%)
Exhibit 26 Global Coronary Stents Market by Product Type 2018−2024 ($ million)
Exhibit 27 Global Coronary Stents Market by Product Type 2018−2024 (%)
Exhibit 28 Global Coronary Stents Market by Product Type: Absolute Growth
Exhibit 29 Global Drug-eluting Coronary Stents Market 2018−2024 ($ million)
Exhibit 30 Global Drug-eluting Stents Market by Product Type
Exhibit 31 Global Drug-eluting Stents Market by Product Type 2018 & 2024 (%)
Exhibit 32 Global Drug-eluting Stents Market by Product Type 2018−2024 ($ million)
Exhibit 33 Global Drug-eluting Stents Market by Product Type 2018−2024 (%)
Exhibit 34 Global Second-generation Drug-eluting Stents Market 2018−2024 ($ million)
Exhibit 35 Global Latest-generation Drug-eluting Stents Market 2018−2024 ($ million)
Exhibit 36 Global Bare Metal Coronary Stents Market 2018−2024 ($ million)
Exhibit 37 Global Bioresorbable Coronary Stents Market 2018−2024 ($ million)
Exhibit 38 Incremental Growth by Design 2018−2024
Exhibit 39 Global Coronary Stents Market by Design Type
Exhibit 40 Global Coronary Stents Market by Design Type 2018 & 2024 (%)
Exhibit 41 Global Coronary Stents Market by Design Type 2018−2024 ($ million)
Exhibit 42 Global Coronary Stents Market by Design Type 2018−2024 (%)
Exhibit 43 Global Coronary Stents Market by Design Type: Absolute Growth
Exhibit 44 Global Permanent Coronary Stents Market by Product 2018 (%)
Exhibit 45 Global Permanent Coronary Stents Market 2018−2024 ($ million)
Exhibit 46 Global Fully Degradable Coronary Stents Market 2018−2024 ($ million)
Exhibit 47 Incremental Growth by End-users 2018−2024
Exhibit 48 Global Coronary Stents Market by End-user Type
Exhibit 49 Global Coronary Stents Market by End-users: Absolute Growth
Exhibit 50 Global Coronary Stents Market by End-user Type 2018 & 2024 (%)
Exhibit 51 Global Coronary Stents Market by End-user Type 2018−2024 ($ million)
Exhibit 52 Global Coronary Stents Market by End-user Type 2018−2024 (%)
Exhibit 53 Global Coronary Stents Hospitals Market 2018–2024 ($ million)
Exhibit 54 Global Coronary Stents Market by SCCs 2018–2024 ($ million)
Exhibit 55 Global Coronary Stents Market by ASCs 2018–2024 ($ million)
Exhibit 56 Incremental Growth by Geography 2018−2024
Exhibit 57 Global Coronary Stents Market by Geography
Exhibit 58 Global Coronary Stents Market by Region: Market Share & CAGR
Exhibit 59 Global Coronary Stents Market by Region: Absolute Growth
Exhibit 60 Global Coronary Stents Market by Geography 2018 & 2024 (%)
Exhibit 61 Global Coronary Stents Market by Geography 2018 & 2024 (%)
Exhibit 62 Global Coronary Stents Market by Geography 2018 & 2024 (%)
Exhibit 63 Coronary Stents Market in North America by Country 2018 (%)
Exhibit 64 Coronary Stents Market in North America 2018–2024 ($)
Exhibit 65 Incremental Growth in North America 2018−2024
Exhibit 66 Coronary Stents Market in US 2018–2024 ($ million)
Exhibit 67 Coronary Stents Market in Canada 2018−2024 ($ million)
Exhibit 68 Coronary Stents Market in Europe: Key Countries
Exhibit 69 Coronary Stents Market in Europe 2018−2024 ($ million)
Exhibit 70 Incremental Growth in Europe 2018−2024
Exhibit 71 Coronary Stents Market in Germany 2018−2024 ($ million)
Exhibit 72 Coronary Stents Market in France 2018−2024 ($ million)
Exhibit 73 Coronary Stents Market in UK 2018−2024 ($ million)
Exhibit 74 Incremental Growth Comparison Across Regions During Forecast Period ($ Mn)
Exhibit 75 Coronary Stents Market in APAC: Key Countries
Exhibit 76 Coronary Stents Market in APAC 2018−2024 ($ million)
Exhibit 77 Incremental Growth in APAC 2018−2024
Exhibit 78 Coronary Stents Market in Japan 2018−2024 ($ million)
Exhibit 79 Coronary Stents Market in China 2018−2024 ($ million)
Exhibit 80 Major Factors Driving Coronary Stents Market in India
Exhibit 81 Coronary Stents Market in India 2018−2024 ($ million)
Exhibit 82 Coronary Stents Market in Latin America: Key Countries
Exhibit 83 Coronary Stents Market in Latin America 2018−2024 ($ million)
Exhibit 84 Incremental Growth in Latin America 2018−2024
Exhibit 85 Coronary Stents Market in Brazil 2018−2024 ($ million)
Exhibit 86 Coronary Stents Market in Mexico 2018−2024 ($ million)
Exhibit 87 Coronary Stents Market in MEA: Key Countries
Exhibit 88 Coronary Stents Market in MEA 2018−2024 ($ million)
Exhibit 89 Incremental Growth in MEA 2018−2024
Exhibit 90 Coronary Stents Market in Turkey 2018−2024 ($ million)
Exhibit 91 Coronary Stents Market in Saudi Arabia 2018−2024 ($ million)
Exhibit 92 Global Coronary Stents Market: Vendors Market Share 2018 (%)
Exhibit 93 Global Coronary Stents Market: Top Vendors Market Shares 2018 (%)
Exhibit 94 Abbott: R&D Spend in FY2016, FY2017 and FY2018 ($ million)
Exhibit 95 Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)
Exhibit 96 Abbott Sales Breakdown by Geography 2018 (%)
Exhibit 97 Boston Scientific: R&D Expenditure in FY16, FY17 and FY18 ($ million)
Exhibit 98 Boston Scientific: Revenue Breakdown by Product Category 2017 and 2018 ($ million)
Exhibit 99 Boston Scientific: Revenue Share by Geography 2018 (%)
Exhibit 100 Medtronic Sales Breakdown by Segments FY2018 (%)
Exhibit 101 Medtronic R&D Expenditure FY16-FY18 ($ million)
Exhibit 102 Medtronic Revenue Breakdown by Geography FY2018 (%)
Exhibit 103 Medtronic Revenue by Business Segments in FY17 and FY18 ($ million)
Exhibit 104 Terumo: Research & Development Spend in FY15, FY16, and FY17 ($ million)
Exhibit 105 Terumo: Sales by Business Segment in FY2017 (%)
Exhibit 106 Terumo: Cardiovascular Revenue by Geography FY2017 (%)
Exhibit 107 B. Braun Melsungen R&D Expenditure in FY16, FY17, and FY18 ($ million)
Exhibit 108 B. Braun Melsungen Revenue by Division FY2017 and FY2018 ($ million)
Exhibit 109 B. Braun Melsungen Sales by Region FY18 (%)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Historical Milestones in Coronary Artery Stenting
Table 4 Popular DESs with Low Strut Thickness
Table 5 Absolute Growth of Coronary Stents in Developed and Emerging Economies (%)
Table 6 12. List of Major Advanced and Innovative Coronary Stents
Table 7 Commercially Available Bioresorbable Coronary Stents
Table 8 Investigational Bioresorbable Coronary Stents
Table 9 12. List of Popular Biodegradable Polymer Coating Drug-eluting Stents
Table 10 Recent Product Approvals in Global Coronary Stents Market
Table 11 12. List of Popular DESs from Prominent Players
Table 12 12. List of Popular BMSs from Prominent Players
Table 13 Commercially Available Bioresorbable Stents
Table 14 Investigational Bioresorbable Stents
Table 15 Global Coronary Stents Market: Vendors Ranking 2018
Table 16 Abbott: Product Offerings
Table 17 Boston Scientific: Key Product Approval Milestone
Table 18 Boston Scientific: Product Offerings
Table 19 Medtronic: Product Offerings
Table 20 BIOTRONIK: Product Offerings
Table 21 Terumo: Product Offerings
Table 22 B. Braun Melsungen’s Therapy Fields & Applications
Table 23 B. Braun Melsungen: Product Offerings
Table 24 Biosensors International Group: Product Offerings
Table 25 Global Coronary Stents Market by Product Type ($ million)
Table 26 Global Coronary Stents Market by Product Type (%)
Table 27 Global Coronary Stents Market by Design ($ million)
Table 28 Global Coronary Stents Market by Design (%)
Table 29 Global Coronary Stents Market by End-users ($ million)
Table 30 Global Coronary Stents Market by End-users (%)
Table 31 Global Coronary Stents Market by Geography ($ million)
Table 32 Global Coronary Stents Market by Geography (%)
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Historical Milestones in Coronary Artery Stenting
Table 4 Popular DESs with Low Strut Thickness
Table 5 Absolute Growth of Coronary Stents in Developed and Emerging Economies (%)
Table 6 12. List of Major Advanced and Innovative Coronary Stents
Table 7 Commercially Available Bioresorbable Coronary Stents
Table 8 Investigational Bioresorbable Coronary Stents
Table 9 12. List of Popular Biodegradable Polymer Coating Drug-eluting Stents
Table 10 Recent Product Approvals in Global Coronary Stents Market
Table 11 12. List of Popular DESs from Prominent Players
Table 12 12. List of Popular BMSs from Prominent Players
Table 13 Commercially Available Bioresorbable Stents
Table 14 Investigational Bioresorbable Stents
Table 15 Global Coronary Stents Market: Vendors Ranking 2018
Table 16 Abbott: Product Offerings
Table 17 Boston Scientific: Key Product Approval Milestone
Table 18 Boston Scientific: Product Offerings
Table 19 Medtronic: Product Offerings
Table 20 BIOTRONIK: Product Offerings
Table 21 Terumo: Product Offerings
Table 22 B. Braun Melsungen’s Therapy Fields & Applications
Table 23 B. Braun Melsungen: Product Offerings
Table 24 Biosensors International Group: Product Offerings
Table 25 Global Coronary Stents Market by Product Type ($ million)
Table 26 Global Coronary Stents Market by Product Type (%)
Table 27 Global Coronary Stents Market by Design ($ million)
Table 28 Global Coronary Stents Market by Design (%)
Table 29 Global Coronary Stents Market by End-users ($ million)
Table 30 Global Coronary Stents Market by End-users (%)
Table 31 Global Coronary Stents Market by Geography ($ million)
Table 32 Global Coronary Stents Market by Geography (%)
